Kingdon Capital Management L.L.C. Makes New Investment in Acadia Healthcare Company, Inc. $ACHC

Key Points

• Kingdon Capital Management L.L.C. has acquired a new stake in Acadia Healthcare, purchasing 422,800 shares valued at approximately $12.81 million, making it their 10th largest position.
• Acadia Healthcare has reported earnings per share of $0.83 for the last quarter, exceeding the consensus estimate of $0.71, along with a revenue of $869.23 million, up 9.2% from the previous year.
• Several institutional investors, including UMB Bank and Caitong International Asset Management, significantly increased their holdings in Acadia Healthcare during the first quarter of the year.

Kingdon Capital Management L.L.C. acquired a new stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) during the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 422,800 shares of the company's stock, valued at approximately $12,819,000. Acadia Healthcare makes up 1.4% of Kingdon Capital Management L.L.C.'s investment portfolio, making the stock its 10th biggest position. Kingdon Capital Management L.L.C. owned about 0.46% of Acadia Healthcare at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. UMB Bank n.a. lifted its holdings in Acadia Healthcare by 149.5% in the 1st quarter. UMB Bank n.a. now owns 1,260 shares of the company's stock valued at $38,000 after acquiring an additional 755 shares during the last quarter. Caitong International Asset Management Co. Ltd grew its stake in shares of Acadia Healthcare by 11,218.2% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 1,245 shares of the company's stock worth $38,000 after purchasing an additional 1,234 shares during the last quarter. State of Wyoming acquired a new position in shares of Acadia Healthcare in the 4th quarter worth approximately $56,000. Covestor Ltd grew its stake in shares of Acadia Healthcare by 56.0% in the 1st quarter. Covestor Ltd now owns 2,262 shares of the company's stock worth $69,000 after purchasing an additional 812 shares during the last quarter. Finally, Aquatic Capital Management LLC acquired a new position in shares of Acadia Healthcare in the 4th quarter worth approximately $97,000.

Analyst Ratings Changes

Several equities analysts have recently issued reports on ACHC shares. KeyCorp lowered their price objective on shares of Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating on the stock in a research note on Wednesday, May 14th. Raymond James Financial reaffirmed an "outperform" rating and issued a $26.00 price objective (down previously from $40.00) on shares of Acadia Healthcare in a research note on Thursday, August 14th. Wall Street Zen raised shares of Acadia Healthcare from a "sell" rating to a "hold" rating in a research note on Sunday, August 3rd. Guggenheim cut their price objective on Acadia Healthcare from $36.00 to $29.00 and set a "buy" rating on the stock in a report on Thursday, August 7th. Finally, Barclays cut their price objective on Acadia Healthcare from $28.00 to $20.00 and set an "equal weight" rating on the stock in a report on Thursday, August 7th. Nine equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $40.77.

Acadia Healthcare Trading Up 2.0%

NASDAQ ACHC traded up $0.46 on Thursday, hitting $23.79. 646,949 shares of the company were exchanged, compared to its average volume of 2,202,105. The company's 50 day moving average price is $22.14 and its 200-day moving average price is $25.17. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.32 and a quick ratio of 1.32. The firm has a market capitalization of $2.20 billion, a P/E ratio of 15.77, a price-to-earnings-growth ratio of 4.52 and a beta of 0.89. Acadia Healthcare Company, Inc. has a twelve month low of $17.13 and a twelve month high of $79.82.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last posted its quarterly earnings data on Tuesday, August 5th. The company reported $0.83 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.71 by $0.12. The firm had revenue of $869.23 million for the quarter, compared to the consensus estimate of $839.59 million. Acadia Healthcare had a return on equity of 8.34% and a net margin of 4.31%.The business's revenue for the quarter was up 9.2% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.91 EPS. Acadia Healthcare has set its FY 2025 guidance at 2.450-2.65 EPS. Analysts predict that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current fiscal year.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.